Advertisement
ELVN vs SER
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and SER is a Hold.
ELVN in downward trend: 10-day moving average crossed below 50-day moving average on September 16, 2026
The 10-day moving average for ELVN crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
ELVN moved below its 50-day moving average on September 11, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for ELVN entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELVN advanced for three days, in 229 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ELVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.766) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ELVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SER in downward trend: price dove below 50-day moving average on September 15, 2026
SER moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 60 of 66 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for SER crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SER declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for SER entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where SER advanced for three days, in 169 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
SER may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.726) is normal, around the industry mean (26.782). P/E Ratio (1.630) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (204.082) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. SER’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ELVN | SER | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 96 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 78 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELVN's Valuation (34) in the null industry is in the same range as SER (54). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.
SER's Profit vs Risk Rating (96) in the null industry is in the same range as ELVN (100). This means that SER’s stock grew similarly to ELVN’s over the last 12 months.
ELVN's SMR Rating (94) in the null industry is in the same range as SER (100). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.
ELVN's Price Growth Rating (62) in the null industry is in the same range as SER (78). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.
ELVN's P/E Growth Rating (100) in the null industry is in the same range as SER (100). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.
| ELVN | SER | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| Advances ODDS (%) | 13 days ago 82% | 10 days ago 84% |
| Declines ODDS (%) | 1 day ago 86% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELVN’s FA Score shows that 0 FA rating(s) are green while SER’s FA Score has 0 green FA rating(s).
- ELVN’s FA Score: 0 green, 5 red.
- SER’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELVN’s TA Score shows that 4 TA indicator(s) are bullish while SER’s TA Score has 4 bullish TA indicator(s).
- ELVN’s TA Score: 4 bullish, 4 bearish.
- SER’s TA Score: 4 bullish, 4 bearish.
Price Growth
ELVN (@Biotechnology) experienced а -5.03% price change this week, while SER (@Biotechnology) price change was -14.93% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -8.52%. For the same industry, the average monthly price growth was -19.04%, and the average quarterly price growth was -19.99%.
Reported Earning Dates
ELVN is expected to report earnings on Nov 18, 2026.
SER is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Biotechnology (-8.52% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SBB | 24.23 | 0.39 | +1.65% |
| ProShares Short SmallCap600 (SBB) | |||
| FMCX | 36.72 | N/A | N/A |
| FM Focus Equity ETF (FMCX) | |||
| MAYZ | 36.82 | -0.39 | -1.06% |
| TrueShares Structured Outcome (May) ETF (MAYZ) | |||
| EEMS | 74.56 | -1.00 | -1.32% |
| iShares MSCI Emerging Markets Small Cap ETF (EEMS) | |||
| CET | 55.09 | -0.98 | -1.75% |
| Central Securities Corp | |||
What is IRS Publication 535, Business Expenses?
What is the Correlation Coefficient, and how does it inform investors?
Top Performer Review: June 23, 2025 — Tickeron’s New FLMs Drive Breakthrough Results in AI Trading
Navigating the Generic Products Market: Top Companies and Financial Insights
Elon Musk Space Empire Forecast 2030 — Planet Labs, Rocket Lab, Intuitive Machines, BlackSky, and Gilat Satellite Are Riding the Structural Shift Toward Commercial Space Infrastructure, Lunar Operations, and Sovereign Intelligence
ELVN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with MLTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then MLTX could also see price increases.
| Ticker / NAME | Correlation To ELVN | 1D Price Change % | ||
|---|---|---|---|---|
| ELVN | 100% | -0.53% | ||
| MLTX - ELVN | 44% Loosely correlated | -2.59% | ||
| WVE - ELVN | 41% Loosely correlated | -1.59% | ||
| CGON - ELVN | 36% Loosely correlated | -0.90% | ||
| CLDX - ELVN | 35% Loosely correlated | -1.47% | ||
| ABVX - ELVN | 35% Loosely correlated | +2.04% | ||
More | ||||
SER and
Correlation & Price change
A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.
| Ticker / NAME | Correlation To SER | 1D Price Change % | ||
|---|---|---|---|---|
| SER | 100% | -6.04% | ||
| GERN - SER | 65% Loosely correlated | -0.83% | ||
| XTLB - SER | 59% Loosely correlated | -4.10% | ||
| ELVN - SER | 37% Loosely correlated | -0.53% | ||
| TOVX - SER | 34% Loosely correlated | -2.69% | ||
| LIFE - SER | 34% Loosely correlated | -1.62% | ||
More | ||||